LGALS9 and neoplasm: However, several studies have reported inconclusive or even opposing results, possibly due to the heterogeneity of tumors with various origins, the divergent roles of Gal-9 in tumor immunity, the diverse expression profiles of receptors, and/or variability in study designs and sample sizes (7).